Masimo Company Description

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide.

It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin.

It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions.

In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers.

Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Masimo Corporation

Country	United States
Founded	1989
Industry	Electromedical and Electrotherapeutic Apparatus
Employees	2,200
CEO	Catherine Szyman

Contact Details

Address: 52 Discovery Irvine, California 92618 United States
Phone	949 297 7000
Website	masimo.com

Stock Details

Ticker Symbol	MASI
Exchange	Mexican Stock Exchange
Stock Type	Common Stock
Fiscal Year	February - January
Reporting Currency	USD
SIC Code	3845

Key Executives

Name	Position
Catherine Szyman	Chief Executive Officer
Micah Young	Chief Financial Officer
Anand Sampath	Chief Operating Officer
Matthew Brinckman	Head of Investor Relations